New surgical mesh tested in facelifts to improve healing
NCT ID NCT07132892
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing a surgical mesh called Galaflex LITE, made from a material called P4HB, in people having a facelift (rhytidectomy). The goal is to see how the mesh affects skin thickness, elasticity, and scarring. Six healthy adults aged 18-80 who are already scheduled for a facelift will be enrolled. The study is purely for research and does not aim to treat a disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Galaflex Lite Scaffold (a surgical mesh made from poly-4-hydroxybutyrate)
- What this could lead to
- If successful, this could show that the mesh improves tissue strength and healing after facelift surgery, potentially leading to better cosmetic outcomes.
- What could go wrong
- This is a very small pilot study with only 6 people, so results may not apply to everyone. The mesh is a device, not a drug, and the study focuses on measuring tissue changes, not treating a disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 6 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Eligibility Criteria Inclusion Criteria 1. Healthy adults 18-80 years of age 2. Planned/scheduled rhytidectomy at UT Southwestern with the study doctor 3. Willing to return for follow up visits and undergo study evaluations Exclusion Criteria 1. Individuals diagnosed with known reaction to device material (tetracycline hydrochloride, kanamycin sulfate, etc) 2. Individuals who have significant scarring on the test area 3. Individuals with a disorder to negatively affect wound healing
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Tissue adhesion are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States